CFA
ARNA

Carroll Financial Associates’s Arena Pharmaceuticals Inc ARNA Stock Holding History

Carroll Financial Associates’s Portfolio ARNA Stock Details ARNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-1,050
Closed -$78K – 1728
2020
Q3 		$78K Buy
+1,050
New +$70K 0.01% 539

Other funds holding ARNA

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return
Alkeon Capital Management
Alkeon Capital Management New York $59.5B AUM 51.63% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Carroll Financial Associates's ARNA Position: Q4 2020 in Review

Carroll Financial Associates sold out of Arena Pharmaceuticals Inc (ARNA) in Q4 2020, closing a stake of 1,050 shares — an estimated $78K sold.

Carroll Financial Associates first reported a position in ARNA in Q3 2020 and held it in 1 quarter. The position peaked at $78K in Q3 2020. 254 funds tracked by Wall St. Rank hold ARNA as of Q4 2020.

  • Carroll Financial Associates reported no remaining Arena Pharmaceuticals Inc position as of Q4 2020 after selling out during the quarter.
  • Carroll Financial Associates sold 1,050 Arena Pharmaceuticals Inc shares in Q4 2020, an estimated $78K.
  • Carroll Financial Associates first reported a position in Arena Pharmaceuticals Inc in Q3 2020 and held it in 1 quarter.
  • Carroll Financial Associates's Arena Pharmaceuticals Inc position peaked at $78K in Q3 2020.
  • 254 funds tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q4 2020.

Based on Carroll Financial Associates's 13F filing for Q4 2020, filed 8 Jan 2021.